New York City, NY -- (SBWIRE) -- 10/14/2013 -- StockMarketIntel.com issues a special report on the following stocks: Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY), Pfizer Inc. (NYSE:PFE), IAMGOLD Corp (USA) (NYSE:IAG), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) declined -1.09%, trading on 785,642shares, to end the trade at $15.43. If we look at its trading history of the past 52 weeks, the share price suffered a low of $10.34 and was moved to the maximum level of $15.61. The stock changed hands in a range of $15.34 to $15.44, bringing its market capitalization to about $68.65 billion. Deutsche Telekom AG is a Germany-based integrated telecommunications provider offering its customers around the world a portfolio of services in the areas of telecommunications and information technology (IT). The Company diversifies its activities into three geographical segments: Germany, Europe and USA; as well as operates the Systems Solutions, and Group Headquarters & Shared Services operating segments.
Has DTEGY Found The Bottom and Ready To Move Up? Find Out Here
Pfizer Inc. (NYSE:PFE) declined -0.17%, to complete the trading session at $28.72, with a total volume of 24.40 million shares. The stock, on average, trades on a volume of 25.04 million shares. In the past 52 weeks, the share price has not declined below $23.55 and above $31.15. It floated in a range of $28.63 to $28.93 during the last trading session, with a beta value of 0.73. Its market capitalization now moved to about $190.14 billion. Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products.
Has PFE Found The Bottom And Ready To Gain Momentum? Find Out Here
IAMGOLD Corp (USA) (NYSE:IAG) recorded a fall of -2.01% and was in a range of $4.32-$4.46 before closing at $4.38. The share price hit its 52-week low of $3.81 and $16.30 was the best price. The stock completed the day with a total volume of 6.02 million shares, versus an average volume of 8.52 million shares. IAMGOLD Corporation (IAMGOLD) is a mining company. IAMGOLD‘s interests include five operating gold mines, a niobium mine, a diamond royalty, and exploration and development projects located in Africa and the Americas. IAMGOLD is focused in West Africa, select countries in South America and in the Canadian province of Quebec. The Company's operating mines include Rosebel Gold Mine, Essakane Gold Mine, Doyon Division Gold Mines and Niobec Niobium Mine.
Why Should Investors Buy IAG After the Recent Fall? Just Go Here and Find Out
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) declined -4.00%, bringing its market capitalization around $139.64 million. The total number of shares that changed hands during the session was 4.34 million shares, as compared to average trading volume of 2.56 million shares. The share price, after opening at $2.62, made a high of $2.77 and hovered above $2.38 to end the day at $2.64. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011, the Company had two drugs in development: CPP-109 and CPP-115.
Will CPRX Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)